Sodium-glucose transporter 2 inhibitors (SGLT2 inhibitors) are a class of medications used in the treatment of type 2 diabetes mellitus. They work by inhibiting the action of the sodium-glucose co-transporter 2 (SGLT2) protein in the kidneys.
Unit 8,
Reference: Oxford Concise Medical Dictionary (9th ed) Oxford University Press 2015 ISBN-13: 9780199687817, p2337
